Novartis and University of Pennsylvania in Broad Cancer Immunotherapy Alliance
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 14 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1788 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Novartis has formed a broad alliance with the University of Pennsylvania (UPenn) for the research, development and commercialisation of targeted chimeric antigen receptor (CAR) cancer immunotherapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS